The diagnostic evaluation for GRS involves documentation of biochemical hypercortisolism with elevated or inappropriately normal ACTH levels, reflecting central resistance to glucocorticoid signaling, testing for mineralocorticoid and androgen excess, and genetic sequencing of the NR3C1 gene. The gene discussed is POMC; the disease is adrenal gland hyperfunction.